Showing results (211-220 of 419) with videos related to

Sort By:
Pageof 42
The Oncologist|January 25, 2021
Pembrolizumab in Patients with Advanced Metastatic Germ Cell TumorsApostolia-Maria Tsimberidou, Henry Hiep Vo, Vivek Subbiah, et al.
The Lancet. Oncology|September 15, 2022
Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trialVivek Subbiah, Jürgen Wolf, Bhavana Konda, et al.
Critical Reviews in Oncology/Hematology|July 2, 2024
From theory to practice: Implementing next-generation sequencing and public health genomics in healthcare systemsDenis Horgan, Filippo Pesapane, Marc Van der Buckle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, et al.
Oncology Research and Treatment|September 13, 2021
A Phase 1 Study of a CDH6-Targeting Antibody-Drug Conjugate in Patients with Advanced Solid Tumors with Evaluation of Inflammatory and Neurological Adverse EventsPatrick Schöffski, Nicole Concin, Cristina Suarez, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2022
Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket studyFederico Longo-Muñoz, Daniel Castellano, Jerome Alexandre, et al.
JCO Precision Oncology|December 5, 2025
Clinical Presentation of MTAP Deletions in Real-World Settings: Lessons for the Clinical Development of Novel Targeted TherapiesJordan T Best, Xiaotong Fu, Sripraharsha S Jampana Raju, et al.
The Oncologist|March 17, 2021
Overview of Ocular Side Effects of SelinexorNagham Al-Zubidi, Dan S Gombos, David S Hong, et al.
Cancer Medicine|February 24, 2024
Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumorsNiamh Coleman, Bettzy Stephen, Siqing Fu, et al.
Journal for Immunotherapy of Cancer|December 20, 2017
Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trialsRoman Groisberg, David S Hong, Amini Behrang, et al.
Pageof 42